Advance Search
JIA Manqing, WANG Yang, CAI Jing, Liu Jun. Association between paraoxonase-1 Q192R gene polymorphism and clopidogrel resistance in patients with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 61-65. DOI: 10.7619/jcmp.20220834
Citation: JIA Manqing, WANG Yang, CAI Jing, Liu Jun. Association between paraoxonase-1 Q192R gene polymorphism and clopidogrel resistance in patients with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 61-65. DOI: 10.7619/jcmp.20220834
shu

Association between paraoxonase-1 Q192R gene polymorphism and clopidogrel resistance in patients with acute myocardial infarction

  • 1.

    Department of Pharmacy, the Seventh Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830028

  • 2.

    Laboratory Medicine, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830028

More Information
  • Received Date: March 15, 2022
  • Available Online: September 02, 2022
    Graphical Abstract
    • Abstract
  • Objective 

    To analyze the correlation between paraoxonase-1 (PON1) Q192R gene polymorphism and clopidogrel resistance in patients with acute myocardial infarction.

    Methods 

    A total of 135 patients with acute myocardial infarction were selected as research objects. All patients were treated with standard clopidogrel for 5 consecutive days and post-discharge for 12 months continuously. After 12 months of medication, the platelet aggregation rate was measured in the hospital. Patients were divided into resistance group (aggregation rate >50%) and sensitive group (≤50%) according to platelet aggregation rate. PON1 Q192R gene polymorphism was detected by fluorescence in situ hybridization.

    Results 

    Platelet aggregation was determined in 135 patients with acute myocardial infarction, 103 cases (76.30%) in the sensitive group and 32 cases (23.70%) in the resistance group. The incidence rates of heterozygous and homozygous single nucleotide polymorphisms (SNP) of PON1 Q192R gene distribution in the resistance group were significantly higher than those in the sensitive group (P < 0.05). The incidence of end-point events at one year after operation in the resistance group was significantly higher than that in the sensitive group (P < 0.05). The platelet aggregation rate of adenosine diphosphate (ADP) and the incidence of major adverse cardiovascular events (MACE) in PON1 Q192R wild-type were significantly lower than those in PON1 Q192R mutant (P < 0.05). PON1 Q192R gene mutation and ADP platelet aggregation ratewere risk factors for MACE in patients with acute myocardial infarction (P < 0.05). SNP heterozygous type and SNP homozygous type of PON1 Q192R gene were significantly correlated with clopidogrel resistance (P < 0.05).

    Conclusion 

    PON1 Q192R gene polymorphisms has higher correlation with clopidogrel resistance in patients with AMI.

    • FullText(HTML)
    • References (15)
  • [1]
    ZEYMER U, BUENO H, GRANGER C B, et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology[J]. Eur Heart J Acute Cardiovasc Care, 2020, 9(2): 183-197. doi: 10.1177/2048872619894254
    [2]
    KIM C J, PARK M W, KIM M C, et al. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial[J]. Lancet, 2021, 398(10308): 1305-1316. doi: 10.1016/S0140-6736(21)01445-8
    [3]
    张晶, 刘佳, 陆康生, 等. CYP2C19、PON1-Q192R基因多态性与急性冠脉综合征患者行PCI术后抗血小板治疗药效的相关性研究[J]. 中国医院药学杂志, 2020, 40(14): 1544-1548. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ202014010.htm
    [4]
    后世翔, 方存明, 栾家杰, 等. CYP2C19、ABCB1和PON1基因多态性对ACS病人PCI术后氯吡格雷治疗的影响[J]. 蚌埠医学院学报, 2021, 46(5): 606-610. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG202105013.htm
    [5]
    中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2010, 38(8): 675-690. doi: 10.3760/cma.j.issn.0253-3758.2010.08.002
    [6]
    BARRAGAN P, BOUVIER J L, ROQUEBERT P O, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation[J]. Catheter Cardiovasc Interv, 2003, 59(3): 295-302. doi: 10.1002/ccd.10497
    [7]
    CHANG C J, TUNG Y C, LIU J R, et al. Efficacy and safety of ticagrelor vs. clopidogrel in east Asian patients with acute myocardial infarction: a nationwide cohort study[J]. Clin Pharmacol Ther, 2021, 109(2): 443-451. doi: 10.1002/cpt.2011
    [8]
    王焱, 程鹏, 王大同, 等. 非致残性缺血性脑血管事件病人氯吡格雷抵抗的临床相关因素分析[J]. 安徽医药, 2021, 25(8): 1577-1581. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY202108024.htm
    [9]
    杨禹娟, 田刚, 王亚萍, 等. 老年冠心病患者经皮冠状动脉介入治疗后氯吡格雷抵抗与CYP2C19基因多态性的关系研究[J]. 中国心血管病研究, 2019(7): 656-660. https://www.cnki.com.cn/Article/CJFDTOTAL-SYXL201803009.htm
    [10]
    刘佳星, 王冰, 邢继成, 等. MiR140-5p在HepG2细胞中对对氧磷酶1表达的调控及其临床应用[J]. 临床检验杂志, 2019, 37(2): 137-141. https://www.cnki.com.cn/Article/CJFDTOTAL-LCJY201902014.htm
    [11]
    丁柏宇, 赵军礼. 冠心病人群氯吡格雷抵抗与基因多态性的研究进展[J]. 医学综述, 2020, 26(19): 3801-3805, 3813. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS202019013.htm
    [12]
    邓树强. 对氧磷酶-1 Q192R基因多态性与氯吡格雷治疗冠心病疗效之间相关性的研究进展[J]. 牡丹江医学院学报, 2019, 40(5): 106-109. https://www.cnki.com.cn/Article/CJFDTOTAL-MDJB201905033.htm
    [13]
    石蕊, 卢姗, 王微, 等. PON1 Q192R基因多态性与氯吡格雷治疗的脑梗死患者复发相关性研究[J]. 中国医药导报, 2021, 18(11): 82-85. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202111021.htm
    [14]
    戴玉洋, 李嘉静, 武峰, 等. 细胞色素P450 2C19、对氧磷酶1基因多态性与氯吡格雷抵抗的关联性研究[J]. 中国临床药理学杂志, 2019, 35(4): 334-337. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201904006.htm
    [15]
    向乾才, 罗廷福, 张娟, 等. 氯吡格雷片联合阿司匹林肠溶片治疗急性冠状动脉综合征患者的预后与对氧磷酶1Q192R基因多态性的相关性[J]. 中国临床药理学杂志, 2021, 37(12): 1487-1490. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202112002.htm
    • Related Articles

  • Related Articles

    [1]LIU Bin, ZHANG Min, LI Xiangang, YANG Zhimin, ZHOU Fang, HUANG Chenbin, CHEN Yangbao, YANG Demei. Correlation between single nucleotide polymorphism rs1333049 and susceptibility to coronary heart disease of Yi ethnic people in frontier plateau area[J]. Journal of Clinical Medicine in Practice, 2022, 26(17): 24-28, 36. DOI: 10.7619/jcmp.20220678
    [2]WANG Xu, LU Xiaofeng, ZHANG Pengbin, LI Yongnan, GAO Bingren. Research progress on correlation between congenital heart disease and hypoxia environment in plateau area[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 109-113. DOI: 10.7619/jcmp.20210086
    [4]QIN Guangzhen, GUO Ling, LIU Hua, WEI Aichun. Clinical effect of perioperative humanistic nursing for tibia plateau fracture patients with minimally invasive treatment[J]. Journal of Clinical Medicine in Practice, 2016, (22): 93-96. DOI: 10.7619/jcmp.201622029
    [5]DAI Zhongming, LIU Ping, LEI Ting, ZHANG Weiping, NIE Zhanguo. Influence of plateau and cold environment on NO expression of gastric mucosa and gastric mucosal injury in rats[J]. Journal of Clinical Medicine in Practice, 2016, (21): 1-3. DOI: 10.7619/jcmp.201621001
    [6]DU Lijuan. Effect of modular rehabilitation program on the functional rehabilitation of knee joint in tibial plateau fracture patients[J]. Journal of Clinical Medicine in Practice, 2016, (4): 93-96. DOI: 10.7619/jcmp.201604029
    [7]DU Wei, XIE Zhenggao, ZHU Jun, CHEN Fang. Efficacy of intravitreal injection of ranibizumab in treatment of patients with idiopathic choroidal neovascularization[J]. Journal of Clinical Medicine in Practice, 2015, (24): 50-52,79. DOI: 10.7619/jcmp.201524015
    [8]XU Min, JIA Li-Li, WU Ting-ting, HU Die, ZHANG Qing, WANG Hui, XIE Yuan-yuan. The nursing of Rituximab in the treatment of refractory nephrotic syndrome in 18 children[J]. Journal of Clinical Medicine in Practice, 2012, (2): 87-88. DOI: 10.3969/j.issn.1672-2353.2012.02.036

  • Cited by

    Periodical cited type(7)

    1. 宋士磊. 64排CT后处理技术诊断原发性肝癌的临床价值. 医药前沿. 2025(07): 66-68+72 .
    2. 贾哲，张海涛，李培鑫，刘坤，马超. 基于倾向性评分匹配对比肝切除并微波消融与TACE治疗多发性肝癌的临床效果. 山东医药. 2024(01): 52-55 .
    3. 尹玲. 增强CT扫描对TAEC术后原发性肝癌患者疗效评估研究. 医药论坛杂志. 2024(05): 543-546 .
    4. 桂颖颖，张圆. CT增强扫描和MRI检查在原发性肝癌患者诊断中的应用价值比较. 中国卫生标准管理. 2024(14): 106-109 .
    5. 朱桂荣. 原发性肝癌患者临床诊断中CT增强扫描的应用价值. 现代诊断与治疗. 2024(17): 2633-2635 .
    6. 卢方. 磁共振成像与多层螺旋CT在原发性肝癌诊断中的效能比较. 中国民康医学. 2023(21): 97-99 .
    7. 高翔，李含静，张明佳. 原发性肝癌综合性介入治疗疗效评价. 中外医疗. 2023(26): 66-69 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (139) PDF downloads (11) Cited by(7)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return